NASDAQ
OPK
Last Price
US $1.4
KEY FIGURES
MKT CAP
$1.0B
EPS
TTM
$-0.10
EPS Growth (1Y)
291.13%
PEG
TTM
N/M
P/E
TTM
N/M
P/S
TTM
1.80x
YIELD
-
GROWTH (5Y CAGR)
Profit margin
Current Ratio
Capital Returns
-5.88%
Return on equity
ROIC: -9.07%
Valuation History
-
Price to Earnings
EV/EBITDA: 24.4X
Cash flow
Profit margin
Revenue
-15.82%
EBITDA
-
Cash flow
-
Cash Flow (DCF)
Fair Value
Market $1.4
—
Default assumptions
EBITDA Multiple
Fair Value
Market $1.4
—
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.
Valuation
Financial
Performance
Cash flow to debt coverage
OPKO Health, Inc. cash flow to debt ratio of -41.18% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.
Free cash flow growth
OPKO Health, Inc.'s free cash flow has increased -8.48% from $-208.50M last year to $-190.82M, signaling increasing performance
Debt-to-equity ratio
OPKO Health, Inc.'s debt to equity ratio is 0.33, which means that the company's assets are healthy financed, signaling financial stability.
Debt-to-equity trend
OPKO Health, Inc.'s debt has decreased relative to shareholder equity from 0.37 last year to 0.33 today, signaling strengthened financials
Net debt to EBITDA
OPKO Health, Inc. has negative EBITDA, making leverage ratio unreliable
Interest coverage
OPKO Health, Inc.'s interest coverage ratio is -3.33, which means that the company struggles to meet interest obligations, signaling financial risk.
Profit margin growth
OPKO Health, Inc.'s profit margin has decreased (66.13%) in the last year from -7.46% to -12.40%, signaling decreasing performance
Current ratio
OPKO Health, Inc.'s short-term assets of $581.88M exceed its short-term liabilities of $146.68M
Return on assets
OPKO Health, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization
Return on equity
OPKO Health, Inc.'s return on equity of -5.88%, is lower than 15.00%, indicating bad performance
Earnings quality
OPKO Health, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation
Earnings stability
OPKO Health, Inc. had positive net income in only 0 out of 5 years, indicating unstable earnings
Positive free cash flow
OPKO Health, Inc. has negative free cash flow, indicating the company is burning cash rather than generating it
Free cash flow yield
OPKO Health, Inc. has negative free cash flow, indicating cash burn
Earnings growth
OPKO Health, Inc.'s yearly earnings has decreased 324.02% since last year from $-53.22M to $-225.68M, signaling decreasing performance
Revenue growth
OPKO Health, Inc.'s yearly revenue has decreased 14.90% since last year from $713.14M to $606.88M, signaling decreasing performance
Return on invested capital
ROIC -9.07% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.
3-year revenue CAGR
OPKO Health, Inc.'s 3-year revenue CAGR of -15.45% is negative, indicating declining revenue over the past 3 years
Revenue consistency
OPKO Health, Inc. had revenue growth in only 1 out of 5 years, indicating inconsistent revenue performance
Return on equity consistency
OPKO Health, Inc. had positive ROE in only 0 out of 5 years, indicating inconsistent returns on equity
Cash Flow Valuation (DCF)
OPKO Health, Inc. has insufficient data to evaluate this check.
Earnings yield (TTM)
OPKO Health, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
EBITDA Valuation
OPKO Health, Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model
EV/EBITDA (FY)
OPKO Health, Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable
PEG ratio (TTM/FY)
OPKO Health, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Price-to-book ratio (FY)
OPKO Health, Inc. has a price-to-book ratio of 0.89x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Price-to-sales ratio (TTM)
OPKO Health, Inc. has a price-to-sales ratio of 1.79x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue